Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.53 |
| ▸ | FBP1 | P09467 | 1/20 | 0.51 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.46 |
| ▸ | AURKA | O14965 | 1/20 | 0.46 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.46 |
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.46 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.46 |
| ▸ | PAK4 | O96013 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | CSF1R | P07333 | 1/20 | 0.46 |
| ▸ | RET | P07949 | 1/20 | 0.46 |
| ▸ | MET | P08581 | 1/20 | 0.46 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.46 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.46 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.46 |
| ▸ | PRKACA | P17612 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2592673 | 0.77 | HSP90AA1 (0.46) | MAPTCHEK1AURKADAPK3JAK2 | |
| SCHEMBL11828494 | 0.76 | CHEK1 (0.45) | MAPTCHEK1AURKADAPK3JAK2 | |
| SCHEMBL29376467 | 0.76 | NPC1 (0.47) | MAPTCHEK1AURKADAPK3JAK2 | |
| SCHEMBL11833908 | 0.75 | MMP2 (0.42) | MAPTCHEK1AURKADAPK3JAK2 | |
| Nifurthiazole SCHEMBL194337 | 0.75 | HSP90AA1 (0.45) | MAPTCHEK1AURKADAPK3JAK2 | |
| SCHEMBL3824030 | 0.75 | RAB9A (0.62) | MAPTABL1HSD17B10NPC1RAB9A | |
| SCHEMBL11830238 | 0.74 | CHEK1 (0.43) | MAPTCHEK1AURKADAPK3JAK2 | |
| SCHEMBL11832826 | 0.74 | CHEK1 (0.49) | MAPTCHEK1AURKADAPK3JAK2 | |
| SCHEMBL3293364 | 0.73 | MMP2 (0.46) | MAPTCHEK1AURKADAPK3JAK2 | |
| SCHEMBL1997012 | 0.73 | MGAM (0.53) | MAPTCHEK1AURKADAPK3JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4562576-A1 | NON-FUNGIBLE TOKEN MANAGEMENT SYSTEMS AND METHODS FOR AN ENTERTAINMENT VENUE | Universal City Studios LLC (US) | 2025-06-04 | — | — | EP | claimed |
| CN-118279557-A | Scene self-adaptive sparse-based lightweight target detection method | 中国科学技术大学 | 2024-07-02 | — | — | CN | claimed |
| WO-2024025894-A1 | NON-FUNGIBLE TOKEN MANAGEMENT SYSTEMS AND METHODS FOR AN ENTERTAINMENT VENUE | UNIVERSAL CITY STUDIOS LLC (US) | 2024-02-01 | — | — | WO | claimed |
| CN-115551880-A | Detecting pancreatic neuroendocrine tumors | 梅约医学教育与研究基金会 | 2022-12-30 | — | — | CN | claimed |
| WO-2022076800-A1 | APPARATUS AND METHODS TO INSTANTIATE AND TRANSACT NFTS USING ATOMIC INSTRUCTIONS WITHOUT SMART CONTRACTS | CONLEY JOHN P (US) | 2022-04-14 | — | — | WO | claimed |
| US-20260126444-A1 | Biomarkers for Long COVID | UNIV SZEGEDI (HU) | 2026-05-07 | — | — | US | disclosed |
| US-20260125772-A1 | Biomarkers for Long COVID | UNIV SZEGEDI (HU) | 2026-05-07 | — | — | US | disclosed |
| WO-2026089862-A1 | SINGLE 2D DIGITAL IMAGE CAPTURE SYSTEM PROCESSING, DISPLAYING OF 3D DIGITAL IMAGE SEQUENCE | NIMS JERRY (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-4689968-A1 | SYSTEMS, APPARATUSES, AND METHODS FOR DECENTRALIZED GENERATION, STORAGE, AND/OR MANAGEMENT OF ENCRYPTED DATA CROSS-REFERENCE TO RELATED APPLICATIONS | DEDI Corp. (CA) | 2026-02-11 | — | — | EP | disclosed |
| EP-4665231-A1 | SELECTIVE VISUAL DISPLAY | Decharms, Richard, Christoher (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250320479-A1 | MUTANTS HAVING EFFICIENT TRANSFRUCTOSYLATION ACTIVITY | REVELATIONS BIOTECH PRIVATE LTD (IN) | 2025-10-16 | — | — | US | disclosed |
| US-20250225512-A1 | SYSTEMS AND METHODS OF USING THE BLOCKCHAIN TO ALLOW MUSIC ARTISTS TO RAISE AND DISTRIBUTE CAPITAL | MEINZER JASON (US) | 2025-07-10 | — | — | US | disclosed |
| CN-114826999-A | Satellite network data transmission method and device | 北京邮电大学 | 2022-07-29 | — | — | CN | disclosed |
| US-20220235389-A1 | Design of Protein Glycosylation Sites by Rapid Expression and Characterization of N-Glycosyltransferases | NORTHWESTERN UNIVERSITY (US) | 2022-07-28 | — | — | US | disclosed |
| WO-2022159148-A1 | EFFICIENT, ACCURATE, AND SECURE DIGITAL ASSET CONVERSIONS FOR REAL-TIME FUNDING OF MERCHANT TRANSACTIONS | Bakkt Marketplace, LLC (US) | 2022-07-28 | — | — | WO | disclosed |
| WO-2022140706-A1 | IMMUNE-REGULATORY LI-KEY PEPTIDE VACCINES FOR PROPHYLAXIS AND LONG-TERM PROTECTION AGAINST SARS-COV-2 INFECTION AND COVID-19 DISEASE | PURCELL RICHARD D (US) | 2022-06-30 | — | — | WO | disclosed |
| US-20100162416-A1 | Multi-stage stem cell carcinogenesis | STEMLIFELINE, INC. (US) | 2010-06-24 | — | — | US | disclosed |
| WO-2010037134-A2 | MULTI-STAGE STEM CELL CARCINOGENESIS | STEMLIFELINE, INC. (US) | 2010-04-01 | — | — | WO | disclosed |
| US-4267102-A | Bleomycin group antibiotics | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1981-05-12 | — | — | US | disclosed |
| US-3957766-A | BACTERIOSTATS, BACTERICIDES | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125772-A1 | Biomarkers for Long COVID | MTREX, POLRMT, NDUFAB1 | MAPT 2350/4885FBP1 3334/4885CHEK1 3105/4885 |
| US-20260126444-A1 | Biomarkers for Long COVID | ATG4B, MFN2, DNM1L | MAPT 1123/4885FBP1 2226/4885CHEK1 4291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.